JENNIFER STRICKLAND: Open Payments
NPI 1831467729 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 30 payments from 10 companies in 2025. Trend: 2023 $900 · 2024 $1,386 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $209 |
| Novo Nordisk Inc | 4 | $67 |
| Janssen Biotech, Inc. | 3 | $64 |
| Abbott Laboratories | 2 | $46 |
| Boston Scientific Corporation | 1 | $32 |
| Amgen Inc. | 2 | $32 |
| Astellas Pharma US Inc | 2 | $30 |
| PFIZER INC. | 2 | $28 |
| Exact Sciences Corporation | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
Products named: VRAYLAR, TREMFYA, FREESTYLE LIBRE 3, Wegovy, UBRELVY, QULIPTA, WATCHMAN FLX, OTEZLA.
Industry payments across KS — which companies pay providers there.
